Merck (MEX:MRK) FFO


MEX:MRK Merck & Co Inc MEX:MRK
72 GF Score
Price MXN2,241.00
GF Value MXN2,062.64
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Merck FFO?

FFO (Funds from operations) only applies to REITs.

MEX:MRK
72GF Score
Merck & Co Inc MEX:MRK
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Merck (MEX:MRK) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of MXN2,241.00 is trading 8.6% above its estimated GF Value™ of MXN2,062.64. GuruFocus considers Merck to be Fairly Valued.

Key valuation signals for MEX:MRK:

  • FFO:
  • GF Value™: MXN2,062.64 vs. price of MXN2,241.00 (8.6% above fair value)
  • GF Score™: 72/100 with 7 warning signs

No single metric tells the full story. See the MEX:MRK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
72GF Score

Get the complete analysis for MEX:MRK

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,241.00
Price
MXN2,062.64
GF Value